CO-102862

N/A

Report date: 2022/02/18 13:45:05

NME

Base Information

Drug NameCO-102862

Drug Alias NameV-102862CO-102862

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSodium channel alpha subunit blockers

TargetsSodium channel alpha subunit

Therapy Area/IndicationsEpilepsy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPurdue Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPurdue Pharma

Active IndicationsN/A

Inactive IndicationsEpilepsy

ATC CodeN/A